Specifically, the accumulation of activated innate immune cells in metabolic tissues results in release of inflammatory mediators, in particular, IL-1β and TNF-α, which promote systemic insulin resistance and β-cell damage6. This evidence concerns the gene IL1B and Insulin resistance.